Chargement en cours...
Therapeutic strategies for acute intermittent porphyria
Acute intermittent porphyria (AIP) is an autosomal dominant disease caused by mutations in porphobilinogen deaminase (PBGD), the third enzyme of the heme synthesis pathway. Symptoms of AIP usually manifest as intermittent acute attacks with occasional neuropsychiatric crises. The management of AIP i...
Enregistré dans:
| Publié dans: | Intractable Rare Dis Res |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
International Research and Cooperation Association for Bio & Socio-Sciences Advancement
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7586882/ https://ncbi.nlm.nih.gov/pubmed/33139979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5582/irdr.2020.03089 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|